Keyword: pharmaceutical industry

News

Human Stool Treatment Upends Race to Treat Colon Germ

30.11.2012 - Drugmakers racing to develop medicines and vaccines to combat a germ that ravages the gut and kills thousands have a new challenger: the human stool. For patients hit hardest by...

News

Bayer Sues Lupin Over Generic Birth Control Pill

30.11.2012 - German drugmaker Bayer has filed a lawsuit in the United States against Indian generic drug maker Lupin, to prevent it from selling a version of Bayer's birth control pill Natazia...

News

Ranbaxy Halts Generic Lipitor Production After Recall

30.11.2012 - Indian generic drugmaker Ranbaxy Laboratories will stop manufacturing its version of Pfizer's cholesterol fighter, Lipitor, while it gets to the bottom of the cause of a recent...

News

Hovione, Solvias Announce Collaborate on Improved Drug Solubility

29.11.2012 - Hovione and Solvias today announced the establishment of a collaboration focused on the development and GMP supply of pharmaceutical co-crystals. This strengthens Hovione's...

News

Abbott Board Paves Way for Split of Company

29.11.2012 - Abbott Laboratories said on Wednesday that its board approved the planned split of its branded pharmaceuticals business into a separate company and that Abbott investors would...

News

EXCiPACT Signs Agreements Cbs for Certification of Pharmaceutical Excipient Suppliers

29.11.2012 - The EXCiPACT Association - a project of the IPEC Federation - is pleased to announce that it has completed Framework Agreements with two internationally-recognised Certification...

News

GSK and J&J Lead Rivals in Drug Access for Poor

28.11.2012 - Drugmakers - led by GlaxoSmithKline and Johnson & Johnson - are stepping up efforts to ensure their medicines are available and affordable in poor countries, after being attacked...

News

Merck KGaA to Resist Lure of Potential Proceeds from OTC Sale

27.11.2012 - Merck KGaA said it would keep its non-prescription drugs unit even as a tussle over vitamin maker Schiff Nutrition highlighted the rich sale premium it could fetch. Merck's...